Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Maintains Neutral on Xponential Fitness, Lowers Price Target to $9

Author: Benzinga Newsdesk | May 13, 2024 09:05am
Piper Sandler analyst Korinne Wolfmeyer maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $12 to $9.

Posted In: XPOF